Metro News: The largest immune cell cryopreservation bank in Jiangsu Province settled in Changzhou

Changzhou Evening News
News from this newspaper yesterday morning, Jiangsu Baize Cell Biotechnology Co., Ltd., jointly established by Shanghai Cell Therapy Group and Jiangsu Jiuzhou Investment Group, officially opened. The cell cryopreservation bank with a total capacity of 300,000 copies settled in Changzhou is currently the largest immune cell cryopreservation base in the province.

Jiangsu Baize cells are the promoters and practitioners of the "Bai Ze Plan". The initiator of the plan, "Father of Chinese Hepatobiliary Surgery" and academician of the Chinese Academy of Sciences, Wu Mengchao, proposed: 10 years, 60% of patients with the disease will regress their tumors; 30 years Let people live a healthy and happy life to their natural life. The establishment of Jiangsu Baize Cell aims to be a comprehensive base for cell cryopreservation, cell detection, and cell preparation in the region of Jiangsu, the radiation long triangle, and is committed to becoming an urban benchmark enterprise in the cell industry area. Jiangsu Baize Cells advocates that people freeze the immune cells of younger and healthier periods as soon as possible, so as to leave the seeds of hope for future disease prevention and treatment for their own lives.

Ms. Ding Na, President of Shanghai Cell Therapy Group and Chairman of Jiangsu Baize Cell Biotechnology Co., Ltd., introduced: Shanghai Cell Therapy Group, as a cutting-edge high-tech company, has inherited the "Baize Plan" proposed by Academician Wu Mengchao since its establishment.

Continuous innovation, through key technological breakthroughs, strive to make the current price of CAR-T cell therapy as high as one million yuan a product accessible to the public within five years. Jiangsu Baize Cells is also committed to helping everyone with health needs and benefiting the public with sophisticated technology, high-quality products, and high-quality services. As Changzhou people's own cell cryopreservation, Jiangsu Baize Cells will make every effort to build a regional industry benchmark for the cell industry, so that the "Baize Plan" will be deeply cultivated in Changzhou.

As one of the two partners of Jiangsu Baize Cell, Jiuzhou Investment Group has advanced the layout and development of the large-scale health care industry for more than 10 years, successfully built the Jiuzhou Golden East Trinity Health Care Project, and formed a focus on modern manufacturing, modern service industry, Systematic layout of new energy and big health industries. The joint creation of Jiangsu Baize cells with Shanghai Cell Therapy Group is of great significance in the development of its big health industry.

At the opening ceremony, Shanghai Cell Therapy Group Changzhou West Taihu Cell Therapy Frontier Technology Research Institute and Jiangsu Baize Cell officially signed a joint construction agreement to jointly build a cooperation platform on cell therapy technology, which will be guided by tumor immune cell therapy technology and resource Sharing, complementary advantages, actively promote the development and application of cell therapy technology, and lead the high-quality and high-speed development of the cell industry.